id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1809972,fb04bd9c-e3df-4f2b-a2ad-b740c2f5bb3f,Q1,ELI LILLY AND COMPANY,13392,ELI LILLY AND COMPANY,2016,first_quarter,CSP,"Anti-counterfeiting; Patient safety; Drug pedigree, serialization and traceability issues; Drug Quality and Security Act; Protecting Consumers from Illegal Online Drug Sales; Online Pharmaceutical Safety Act; Promoting Public-Private Partnerships","Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,1250000,0,0,2016-04-18T08:44:56.283000-04:00